Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors

High-dose chemotherapy with autologous hematopoietic stem cell transplantation (autoHSCT) is a well-established treatment for pediatric central nervous system (CNS) tumors. Given the risks of toxicity and infection, pediatric autoHSCT has been historically performed on hospitalized children. As our...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Jane, Silverman, Stacy, Nuechterlein, Brandon, Keating, Amy K., Verneris, Michael R., Foreman, Nicholas K., Mulcahy Levy, Jean M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957458/
https://www.ncbi.nlm.nih.gov/pubmed/30783209
http://dx.doi.org/10.1038/s41409-019-0479-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957458/
https://www.ncbi.nlm.nih.gov/pubmed/30783209
http://dx.doi.org/10.1038/s41409-019-0479-3

Ejemplares similares